Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 11/20 | 0.40 |
| ▸ | NPY1R | P25929 | 6/20 | 0.40 |
| ▸ | NPY2R | P49146 | 4/20 | 0.38 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.38 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.37 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.34 |
| ▸ | OTC | P00480 | 1/20 | 0.34 |
| ▸ | ANPEP | P15144 | 2/20 | 0.33 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.33 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.33 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.33 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.33 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9237239 | 0.92 | NPY4R (0.39) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL28712062 | 0.92 | NPY4R (0.39) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL288133 | 0.92 | NPY4R (0.39) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL6762710 | 0.91 | ANPEP (0.35) | NPY4RNPY1RNPY2RNPY5RANPEP | |
| Hydrochloric Acid SCHEMBL8040222 | 0.91 | NPY4R (0.38) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| Hydrochloric Acid SCHEMBL8039440 | 0.91 | NPY4R (0.38) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| Threonine SCHEMBL285577 | 0.90 | NPY4R (0.36) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL15653883 | 0.90 | NPY4R (0.41) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL323016 | 0.90 | NPY4R (0.41) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL30531669 | 0.90 | NPY4R (0.41) | NPY4RNPY1RNPY2RNPY5RDPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024013258-A1 | PRODUCTION OF CYSTEINE OR CYSTINE FROM SERINE IN FERMENTATION MEDIUM | CYSBIO APS (DK) | 2024-01-18 | — | — | WO | claimed |
| CN-110063313-A | A kind of oxygenation bait and preparation method thereof with comprehensive high-tech attracting | 威海猎屋渔具有限公司 | 2019-07-30 | — | — | CN | claimed |
| WO-2014026143-A1 | CONJUGATED ANTI-MICROBIAL COMPOUNDS AND CONJUGATED ANTI-CANCER COMPOUNDS AND USES THEREOF | PONO CORPORATION (US) | 2014-02-13 | — | — | WO | claimed |
| EP-1562578-A1 | THERAPEUTIC DELIVERY OF CARBON MONOXIDE TO EXTRACORPOREAL AND ISOLATED ORGANS | Hemocorm Limited (GB) | 2005-08-17 | — | — | EP | claimed |
| WO-2004045598-A1 | THERAPEUTIC DELIVERY OF CARBON MONOXIDE TO EXTRACORPOREAL AND ISOLATED ORGANS | HEMOCORM LIMITED (GB) | 2004-06-03 | — | — | WO | claimed |
| US-20240185952-A1 | DETECTING LOSS OF HETEROZYGOSITY IN HLA ALLELES USING MACHINE-LEARNING MODELS | PERSONALIS INC (US) | 2024-06-06 | — | — | US | disclosed |
| EP-4327327-A1 | DETECTING LOSS OF HETEROZYGOSITY IN HLA ALLELES USING MACHINE-LEARNING MODELS | Personalis, Inc. (US) | 2024-02-28 | — | — | EP | disclosed |
| WO-2024013258-A1 | PRODUCTION OF CYSTEINE OR CYSTINE FROM SERINE IN FERMENTATION MEDIUM | CYSBIO APS (DK) | 2024-01-18 | — | — | WO | disclosed |
| WO-2023121753-A1 | BIOMOLECULE-POLYMER-PHARMACEUTICAL AGENT CONJUGATES FOR DELIVERING THE PHARMACEUTICAL AGENT | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-06-29 | — | — | WO | disclosed |
| CN-116286420-A | Malate dehydrogenase | 帝斯曼知识产权资产管理有限公司 | 2023-06-23 | — | — | CN | disclosed |
| EP-4186523-A1 | A NOVEL METHOD FOR STABILIZATION OF A BIOPHARMACEUTICAL DRUG PRODUCT DURING PROCESSING | Leukocare AG (DE) | 2023-05-31 | — | — | EP | disclosed |
| CN-109689864-B | Malate dehydrogenase | 帝斯曼知识产权资产管理有限公司 | 2023-04-04 | — | — | CN | disclosed |
| EP-0852946-A2 | Composition for cosmetic, pharmaceutical or dietetic use based on an amino-sugar and/or a polyhydroxylic acid | De Paoli Ambrosi, Gianfranco (IT) | 1998-07-15 | — | — | EP | disclosed |
| US-5514574-A | Method of producing flavine nucleotides | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1996-05-07 | — | — | US | disclosed |
| EP-0542240-A2 | Process for producing flavine nucleotides | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1993-05-19 | — | — | EP | disclosed |
| EP-0541716-A1 | NOVEL METHODS AND COMPOSITIONS FOR TREATMENT OF ANGIOGENIC DISEASES | REPLIGEN CORPORATION (US) | 1993-05-19 | — | — | EP | disclosed |
| US-5189025-A | Administering amino acid mixture | BOARD OF REGENETS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1993-02-23 | — | — | US | disclosed |
| US-5162373-A | Gut Atrophy Prevention, Ornithine, Methionine | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1992-11-10 | — | — | US | disclosed |
| WO-1992002240-A2 | NOVEL METHODS AND COMPOSITIONS FOR TREATMENT OF ANGIOGENIC DISEASES | REPLIGEN CORPORATION (US) | 1992-02-20 | — | — | WO | disclosed |
| US-4988724-A | Anticarcinogenic agents, antitumor agents, amino acids and citrulline and ornithine; arginine-free; antitumor and -carcinogenic agents | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1991-01-29 | — | — | US | disclosed |